News and Events

Clear and unbiased facts about why the COVID 19/Pneumonia relationship is bad news

Mar 30, 2021

Licensing Deal for NP213 Nail Fungus Treatment is Another Key Milestone for NovaBiotics

Feb 26, 2021

NovaBiotics Attending BIO CEO & Investor Digital Conference

Feb 2, 2021

Just when we thought things were getting better…..

Dec 31, 2020

CARE CF 1 oral Lynovex clinical trial data published

Dec 29, 2020

NovaBiotics in the press

Dec 28, 2020

As world antimicrobial awareness week gets underway, our CEO shares her thoughts on the near-term outlook for antimicrobials: the economic case aligning with innovation

Nov 18, 2020

Why, in the current crisis we still need more effective, proven treatments for COVID-19

Nov 17, 2020

Appointment of Dr Malcolm Barratt-Johnson to the Board of NovaBiotics

Nov 10, 2020

The truth about why we need this COVID-19 treatment right now!

Oct 22, 2020